AGP Executive Report
Last update: 9 hours agoMedical Innovation in Tbilisi: BioVentrix says the first two patients in Georgia have been treated at Caucasus Medical Centre with its Revivent System for heart failure under the pivotal RELIVE trial. Prison Health & Rights: Giorgi Davitadze’s family and supporters protest outside Rustavi Prison No. 6 over alleged rape by guards; the Justice Minister says allegations aren’t substantiated and investigations continue, while Davitadze refuses transfer to a clinic and has begun a hunger strike after swallowing metal objects. Public Health at Protests: An OSCE conference presentation shared a survey of 523 demonstrators about possible chemical irritants used during the 2024 Tbilisi protests, but the study says it can’t prove cause-and-effect due to limits like no control group and no independent substance testing. University Safety: Caucasus University denies reports of mass poisoning at a freshmen party, saying students became unwell from alcohol and received medical care; an investigation has been launched. Pharma Industry: Azerbaijan opened a Gen Pharma manufacturing plant in Pirallahi Industrial Park, aiming to localize hundreds of medicines and reduce import dependence.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
